Drug indicated for reducing the of developing skeletal-related events in patients with bone metastases from breast cancer, prostate cancer, non-small cell lung cancer and other solid tumours.
It’s widely known and, sadly, often accepted as standard that doctors’ offices run late. But did you know the degree of tardiness is fairly consistent in a particular office?
CHICAGO | Canadian research shows that men with prostate cancer who are treated with intermittent courses of androgen-suppressing therapy live as long as those who receive continuous therapy.
